Bryant D. Lim - 19 Dec 2024 Form 4 Insider Report for Prelude Therapeutics Inc (PRLD)

Role: CLO, Interim CFO, Corp Sec.
Signature: /s/ Bryant D. Lim
Issuer symbol: PRLD
Transactions as of: 19 Dec 2024
Net transactions value: +$22,638
Form type: 4
Filing time: 20 Dec 2024, 07:35:53 UTC
Previous filing: 16 May 2024
Next filing: 05 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRLD	Common Stock	Purchase	$22,638	+25,000	+1042%	$0.9055	27,400	19 Dec 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.87 to $0.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Content

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.87 to $0.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.